Sciencast Management LP Purchases Shares of 6,300 Celanese Corporation $CE

Key Points

• Sciencast Management LP acquired a new stake in Celanese Corporation, purchasing 6,300 shares valued at approximately $358,000 in the first quarter.
• Institutional investors collectively own 98.87% of Celanese stock, with several firms increasing their holdings significantly during the same period.
• Celanese reported a quarterly EPS of $1.44, exceeding analysts' expectations, despite a 4.5% year-over-year decline in revenue.

Sciencast Management LP purchased a new stake in Celanese Corporation (NYSE:CE - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 6,300 shares of the basic materials company's stock, valued at approximately $358,000.

A number of other large investors have also made changes to their positions in CE. Turtle Creek Asset Management Inc. grew its position in shares of Celanese by 266.7% in the fourth quarter. Turtle Creek Asset Management Inc. now owns 3,506,440 shares of the basic materials company's stock valued at $242,681,000 after purchasing an additional 2,550,334 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Celanese by 134.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,566,226 shares of the basic materials company's stock valued at $202,455,000 after purchasing an additional 2,044,662 shares in the last quarter. Federated Hermes Inc. grew its position in shares of Celanese by 9,132.0% in the first quarter. Federated Hermes Inc. now owns 1,801,349 shares of the basic materials company's stock valued at $102,263,000 after purchasing an additional 1,781,837 shares in the last quarter. Dodge & Cox grew its position in shares of Celanese by 13.0% in the first quarter. Dodge & Cox now owns 15,391,416 shares of the basic materials company's stock valued at $873,771,000 after purchasing an additional 1,773,354 shares in the last quarter. Finally, Voloridge Investment Management LLC purchased a new stake in shares of Celanese in the fourth quarter valued at approximately $59,572,000. 98.87% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CE shares. Alembic Global Advisors set a $60.00 price objective on Celanese in a research report on Monday, August 25th. KeyCorp lowered their price objective on Celanese from $77.00 to $70.00 and set an "overweight" rating for the company in a research report on Wednesday, August 13th. UBS Group lowered their price objective on Celanese from $66.00 to $49.00 and set a "neutral" rating for the company in a research report on Tuesday, August 12th. Jefferies Financial Group lowered their price objective on Celanese from $47.00 to $43.00 and set a "hold" rating for the company in a research report on Monday, September 8th. Finally, Cfra Research upgraded Celanese to a "moderate sell" rating in a research report on Tuesday, August 12th. Six investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have issued a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $57.22.

Celanese Stock Down 2.5%

Shares of NYSE CE traded down $1.17 during mid-day trading on Friday, hitting $45.70. The company had a trading volume of 1,014,011 shares, compared to its average volume of 1,897,838. The company has a market capitalization of $5.00 billion, a PE ratio of -3.08, a price-to-earnings-growth ratio of 2.12 and a beta of 1.11. The company has a debt-to-equity ratio of 2.22, a current ratio of 2.05 and a quick ratio of 1.22. Celanese Corporation has a 1-year low of $36.29 and a 1-year high of $142.54. The business's 50-day simple moving average is $50.72 and its 200 day simple moving average is $51.17.

Celanese (NYSE:CE - Get Free Report) last announced its quarterly earnings data on Monday, August 11th. The basic materials company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.06. The business had revenue of $2.53 billion for the quarter, compared to analysts' expectations of $2.50 billion. Celanese had a positive return on equity of 10.48% and a negative net margin of 16.30%.The company's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period last year, the firm earned $2.38 earnings per share. Celanese has set its Q3 2025 guidance at 1.100-1.400 EPS. On average, analysts predict that Celanese Corporation will post 8.79 earnings per share for the current year.

Celanese Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 11th. Stockholders of record on Tuesday, July 29th were paid a $0.03 dividend. This represents a $0.12 annualized dividend and a dividend yield of 0.3%. The ex-dividend date was Tuesday, July 29th. Celanese's dividend payout ratio (DPR) is presently -0.81%.

Insider Activity

In related news, Director Timothy Go acquired 1,039 shares of Celanese stock in a transaction dated Monday, September 8th. The shares were acquired at an average cost of $46.25 per share, for a total transaction of $48,053.75. Following the completion of the purchase, the director owned 4,415 shares in the company, valued at approximately $204,193.75. The trade was a 30.78% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company's stock.

Celanese Profile

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.